New Once-Daily HIV Oral Alternative Advances
A phase 2 study presented at the Conference on Retrovirus and Opportunistic Infections (CROI) in Denver showed that a once-daily oral combination therapy for HIV consisting of bictegravir plus lenacapavir…
People At High Risk Of Obesity In Middle Age If Parents Were Obese: Study
A study conducted by Norwegian researchers found that individuals whose parents were obese in middle age are at a higher risk of being obese themselves during the same life stage.…
VIMSAR Junior Doctors Threaten Strike over pending stipend
Junior doctors at VIMSAR are threatening to go on strike due to pending stipend payments. They are demanding timely disbursal of their stipends, which have reportedly been delayed for several…
How Should Providers Be Approaching the Generative AI Frenzy?
The U.S. healthcare sector has been slow to undergo digital transformation compared to other industries, leading to a lack of seamless digital experiences for consumers. Bill Fera of Deloitte highlighted…
Calls for nurses and midwives to be exempt from HSE recruitment moratorium
The Irish Nurses and Midwives Organisation (INMO) is urging the Health Service Executive (HSE) to lift the moratorium on recruiting frontline patient-facing staff due to a 13% increase in emergency…
Data Support Earlier COVID-19 Vaccination After HSCT, CAR T-Cell Therapy
New data supports earlier COVID-19 vaccine use in patients who have received a hematopoietic stem cell transplant (HSCT) or CAR T-cell therapy. Research shows that patients vaccinated 3-4 months after…
Dexcom over-the-counter Stelo Glucose Biosensor wins FDA clearance
Dexcom's new over-the-counter continuous glucose monitoring (CGM) solution, Stelo, has been cleared by the FDA. It is a wearable biosensor that provides round-the-clock glucose readings directly to a smartphone. The…
Hospitales de California y defensores buscan financiaciĆ³n estable para retener a navegadores de salud conductual
Los proveedores de salud y expertos en adicciones en California advierten que el programa CA Bridge, que ayuda a pacientes con trastornos por consumo de sustancias a iniciar tratamientos de…
Melatonin sent 11K children to ED in 4 years
A recent study found that 7 out of 10 ED visits for unsupervised medication exposures by infants and young children in the US were due to unsupervised ingestion of melatonin…
Amylyx ALS drug failure raises questions and concerns
The ALS community faces disappointment as Amylyx Pharmaceuticals' drug Relyvrio fails to outperform a placebo in a study, raising questions about its approval in 2022. ALS advocate Mary Catherine Collet…